536565 — Novelix Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹264.77m
- IN₹263.25m
- IN₹42.24m
- 15
- 12
- 94
- 33
Annual cashflow statement for Novelix Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.15 | -37.3 | -15.7 | -0.585 | 0.213 |
| Depreciation | |||||
| Non-Cash Items | -4.96 | -3.07 | 9.68 | -5.16 | -3.07 |
| Extraordinary Items | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 11.5 | 54.2 | 11.2 | -18.9 | -0.955 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6.28 | 15.9 | 5.93 | -24.1 | -3.43 |
| Capital Expenditures | -1.06 | -0.295 | -18.6 | -0.044 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.6 | 1.65 | 21.4 | 0.795 | 1.87 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.54 | 1.36 | 2.75 | 0.751 | 1.87 |
| Financing Cash Flow Items | 0 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.64 | -7.67 | 0 | — | — |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.19 | 9.62 | 8.68 | -23.3 | -1.57 |